Asuragen, Inc., a leading molecular diagnostics company headquartered in the United States, has been at the forefront of innovative solutions since its founding in 2006. With a strong focus on oncology and genetic testing, Asuragen develops cutting-edge products that empower healthcare professionals to make informed decisions. The company’s core offerings include a range of proprietary assays and diagnostic tools that are distinguished by their accuracy and reliability. Asuragen's commitment to advancing precision medicine has positioned it as a key player in the molecular diagnostics industry, with notable achievements in the development of tests for cancer and genetic disorders. With operations extending across major regions in the US and a growing international presence, Asuragen continues to drive advancements in molecular testing, enhancing patient care and outcomes worldwide.
We don't have data for Asuragen, Inc., but we can show you information about their parent organization instead.
View parent company